{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:14:12Z","timestamp":1793452452313,"version":"4.5.0"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Cardiac toxicity may be associated with drugs used for malaria. Torsades de pointes (TdP) is a well-known adverse effect of quinidine when used for atrial fibrillation. Intravenous quinidine doses for resistant malaria are 2 to 3 times higher than those used for arrhythmias. Among 6 patients receiving quinidine for malaria or babesiosis, 4 developed QT interval prolongation and 2 experienced TdP. Clinicians should be aware that recommended doses of quinidine for malaria carry a high TdP risk.<\/jats:p>","DOI":"10.1128\/aac.06396-11","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T02:55:06Z","timestamp":1337655306000},"page":"4495-4499","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":22,"title":["High Risk of QT Interval Prolongation and Torsades de Pointes Associated with Intravenous Quinidine Used for Treatment of Resistant Malaria or Babesiosis"],"prefix":"10.1128","volume":"56","author":[{"given":"Heather A.","family":"Wroblewski","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Kovacs","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA"},{"name":"Krannert Institute of Cardiology, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna R.","family":"Kingery","sequence":"additional","affiliation":[{"name":"the Department of Pharmacy, Indiana University Health Methodist Hospital, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Overholser","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, Indiana, USA"},{"name":"Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, Indiana, USA"},{"name":"Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-8703(00)90317-X","article-title":"Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series","volume":"139","author":"Allen LaPointe NM","year":"2000","unstructured":"Allen LaPointeNM LiP. 2000. Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series. Am. Heart J. 139:114\u2013121.","journal-title":"Am. Heart J."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-8703(84)90081-4","article-title":"Torsade de pointes due to quinidine: observations in 31 patients","volume":"107","author":"Bauman JL","year":"1984","unstructured":"BaumanJL. 1984. Torsade de pointes due to quinidine: observations in 31 patients. Am. Heart J. 107:425\u2013430.","journal-title":"Am. Heart J."},{"key":"e_1_3_2_4_2","first-page":"353","article-title":"An analysis of time relationships of the electrocardiogram","volume":"7","author":"Bazett HC","year":"1920","unstructured":"BazettHC. 1920. An analysis of time relationships of the electrocardiogram. Heart 7:353\u2013370.","journal-title":"Heart"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0736-4679(93)90047-B","article-title":"Delayed cardiotoxicity following quinine overdose: a case report","volume":"11","author":"Bodenhamer JE","year":"1993","unstructured":"BodenhamerJE SmilksteinMJ. 1993. Delayed cardiotoxicity following quinine overdose: a case report. J. Emerg. Med. 11:279\u2013285.","journal-title":"J. Emerg. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2310\/7060.2002.24026","article-title":"Severe cardiac toxicity due to halofantrine: importance of underlying heart disease","volume":"9","author":"Bouchaud O","year":"2002","unstructured":"BouchaudO BruneelF SchiemannR PeytavinG CoulaudJP. 2002. Severe cardiac toxicity due to halofantrine: importance of underlying heart disease. J. Travel Med. 9:214\u2013215.","journal-title":"J. Travel Med."},{"key":"e_1_3_2_7_2","first-page":"1360","article-title":"Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm AJ","year":"2010","unstructured":"CammAJ. 2010. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360\u20131420.","journal-title":"Europace"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1540-8167.2010.01738.x","article-title":"Preferred QT correction formula for the assessment of drug-induced QT interval prolongation","volume":"21","author":"Chiladakis J","year":"2010","unstructured":"ChiladakisJ Kalogeropoulos ArvanitisAP KoutsogiannisN ZagliF AlexopoulosD. 2010. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation. J. Cardiovasc. Electrophysiol. 21:905\u2013913.","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1998.00252.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1991.tb05531.x","article-title":"Population pharmacokinetics of quinidine","volume":"31","author":"Fattinger K","year":"1991","unstructured":"FattingerK VozehS HaHR BornerM FollathF. 1991. Population pharmacokinetics of quinidine. Br. J. Clin. Pharmacol. 31:279\u2013286.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00380-008-1144-8","article-title":"Cardiotoxicity after low-dose chloroquine therapy","volume":"24","author":"Fragasso G","year":"2009","unstructured":"FragassoG. 2009. Cardiotoxicity after low-dose chloroquine therapy. Heart Vessels 24:385\u2013387.","journal-title":"Heart Vessels"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1920.tb18266.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation)","volume":"104","author":"Fuster V","year":"2001","unstructured":"FusterV. 2001. ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 104:2118\u20132150.","journal-title":"Circulation"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)","volume":"114","author":"Fuster V","year":"2006","unstructured":"FusterV. 2006. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 114:700\u2013752.","journal-title":"Circulation"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cjca.2010.11.001","article-title":"CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management","volume":"27","author":"Gillis AM","year":"2010","unstructured":"GillisAM VermaA TalajicM NattelS DorianP. 2010. CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can. J. Cardiol. 27:47\u201359.","journal-title":"Can. J. Cardiol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.109.894725","article-title":"Drug-induced arrhythmia","volume":"122","author":"Heist EK","year":"2010","unstructured":"HeistEK RuskinJN. 2010. Drug-induced arrhythmia. Circulation 122:1426\u20131435.","journal-title":"Circulation"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00007890-199808270-00021","article-title":"QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report","volume":"66","author":"Hodak SP","year":"1998","unstructured":"HodakSP. 1998. QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. Transplantation 66:535\u2013537.","journal-title":"Transplantation"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1023\/A:1009933509868","article-title":"Rate correction of the QT interval","volume":"1","author":"Hodges M","year":"1997","unstructured":"HodgesM. 1997. Rate correction of the QT interval. Cardiac Electrophysiol. Rev. 1:360\u2013363.","journal-title":"Cardiac Electrophysiol. Rev."},{"key":"e_1_3_2_19_2","first-page":"1","article-title":"Malaria surveillance\u2014United States, 2010","volume":"61","author":"Mali S","year":"2012","unstructured":"MaliS KachurSP ArguinPM. 2012. Malaria surveillance\u2014United States, 2010. MMWR Surveill. Summ. 61:1\u201317.","journal-title":"MMWR Surveill. Summ."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/j.1540-8159.1997.tb03613.x","article-title":"Quinine may trigger torsades de pointes during astemizole therapy","volume":"20","author":"Martin ES","year":"1997","unstructured":"MartinES RogalskiK BlackJN. 1997. Quinine may trigger torsades de pointes during astemizole therapy. Pacing Clin. Electrophysiol. 20:2024\u20132025.","journal-title":"Pacing Clin. Electrophysiol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2165\/00003088-198005020-00003","article-title":"Clinical pharmacokinetics of quinidine","volume":"5","author":"Ochs HR","year":"1980","unstructured":"OchsHR GreenblattDJ WooE. 1980. Clinical pharmacokinetics of quinidine. Clin. Pharmacokinet. 5:150\u2013169.","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_3_2_22_2","first-page":"106","article-title":"Torsades-de-pointes-type ventricular tachycardia in a patient with digitalis intoxication under chronic treatment with quinine sulfate","volume":"31","author":"Ram\u00edrez A","year":"2007","unstructured":"Ram\u00edrezA Galv\u00e1nJM. 2007. Torsades-de-pointes-type ventricular tachycardia in a patient with digitalis intoxication under chronic treatment with quinine sulfate. Med. Intensiva 31:106\u2013107.","journal-title":"Med. Intensiva"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"73A","DOI":"10.1016\/S0735-1097(86)80032-8","article-title":"Clinical features and basic mechanisms of quinidine-induced arrhythmias","volume":"8","author":"Roden DM","year":"1986","unstructured":"RodenDM ThompsonKA HoffmanBF WoosleyRL. 1986. Clinical features and basic mechanisms of quinidine-induced arrhythmias. J. Am. Coll. Cardiol. 8(Suppl A):73A\u201378A.","journal-title":"J. Am. Coll. Cardiol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1309\/N3DP9MFPNUJD4XJY","article-title":"Babesiosis. Two atypical cases from Minnesota and a review","volume":"120","author":"Setty S","year":"2003","unstructured":"SettyS KhalilZ SchoriP AzarM FerrieriP. 2003. Babesiosis. Two atypical cases from Minnesota and a review. Am. J. Clin. Pathol. 120:554\u2013559.","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_3_2_25_2","first-page":"485","volume-title":"Drug-induced diseases. Prevention, detection and management","author":"Tisdale JE","year":"2010","unstructured":"TisdaleJE. 2010. Ventricular arrhythmias, p 485\u2013515. In TisdaleJE MillerDA (ed), Drug-induced diseases. Prevention, detection and management, 2nd ed. American Society of Health-Systems Pharmacists, Bethesda, MD.","edition":"2"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIR.0b013e3181fa3cf4","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann LS","year":"2011","unstructured":"WannLS. 2011. 2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 123:104\u2013123.","journal-title":"Circulation"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005344-198303000-00001","article-title":"Quinine and quinidine: a comparison of EKG effects during the treatment of malaria","volume":"5","author":"White N","year":"1983","unstructured":"WhiteN LooareesuwanS WarrellD. 1983. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J. Cardiovasc. Pharmacol. 5:173\u2013175.","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"e_1_3_2_28_2","unstructured":"World Health Organization. 2010. Guidelines for the treatment of malaria 2nd ed. World Health Organization Geneva Switzerland."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.06396-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.06396-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T18:27:05Z","timestamp":1713983225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.06396-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1128\/AAC.06396-11"],"URL":"https:\/\/doi.org\/10.1128\/aac.06396-11","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"2011-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-07-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}